Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients

References

• WebsterKDPharmacodynamics and pharmacogenomicsZdanowiczMMConcepts in PharmacogenomicsBethesda, MDAmerican Society of Health-System Pharmacists2010155180
   Google Scholar
• HalloranPFImmunosuppressive drugs for kidney transplantationN Engl J Med2004351262715272915616206
   PubMed Web of Science ®Google Scholar
• LeeRAGabardiSCurrent trends in immunosuppressive therapies for renal transplant recipientsAm J Health Syst Pharm201269221961197523135563
   PubMed Web of Science ®Google Scholar
• RusnakFMertzPCalcineurin: form and functionPhysiol Rev20008041483152111015619
   PubMed Web of Science ®Google Scholar
• HeZHHuYLiYCAre calcineurin genes associated with athletic status? A function, replication studyMed Sci Sports Exerc20114381433144021233773
   PubMed Web of Science ®Google Scholar
• CottrellJRLiBKyungJWCalcineurin Aγ is a functional phosphatase that modulates synaptic vesicle endocytosisJ Biol Chem201629141948195626627835
   PubMed Web of Science ®Google Scholar
• WangMGYiHGueriniDKleeCBMcBrideOWCalcineurin A alpha (PPP3CA), calcineurin A beta (PPP3CB) and calcineurin B (PPP3R1) are located on human chromosomes 4, 10q21–>q22 and 2p16–>p15 respectivelyCytogenet Cell Genet1996722–32362418978785
   PubMedGoogle Scholar
• PouchéLStojanovaJMarquetPPicardNNew challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugsPharmacogenomics201617327729626799749
   PubMed Web of Science ®Google Scholar
• ChioccoMJZhuXWaltherDFine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5′UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer’s diseaseSubst Use Misuse201045111809182620590401
   PubMed Web of Science ®Google Scholar
• PoirierONicaudVMcDonaghTPolymorphisms of genes of the cardiac calcineurin pathway and cardiac hypertrophyEur J Hum Genet200311965966412939651
   PubMed Web of Science ®Google Scholar
• MoesDJPressRRAckaertOExploring genetic and non-genetic risk factors for delayed graft function, acute and subclinical rejection in renal transplant recipientsBr J Clin Pharmacol201682122723727334415
   PubMed Web of Science ®Google Scholar
• PouchéLKoitkaMStojanovaJA candidate gene approach of the calcineurin pathway to identify variants associated with clinical outcomes in renal transplantationPharmacogenomics201617437539126894651
   PubMed Web of Science ®Google Scholar
• SilvaHTJrFelipeCRGarciaVDPlanned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipientsAm J Transplant201313123155316324266969
   PubMed Web of Science ®Google Scholar
• RacusenLCSolezKColvinRBThe Banff 97 working classification of renal allograft pathologyKidney Int19995527137239987096
   PubMed Web of Science ®Google Scholar
• LeveyASBoschJPLewisJBGreeneTRogersNRothDA more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study GroupAnn Intern Med1999130646147010075613
   PubMed Web of Science ®Google Scholar
• FelixMJFelipeCRTedesco-SilvaHOsmar Medina-PestanaJTime-dependent and immunosuppressive drug-associated adverse event profiles in de novo kidney transplant recipients converted from tacrolimus to sirolimus regimensPharmacotherapy201636215216526799522
   PubMed Web of Science ®Google Scholar
• EdwardsIRAronsonJKAdverse drug reactions: definitions, diagnosis, and managementLancet200035692371255125911072960
   PubMed Web of Science ®Google Scholar
• MedDRAMedical Dictionary for Regulatory Activities Available from: http://www.meddra.orgAccessed January 4, 2016
   Google Scholar
• Database of Single Nucleotide Polymorphisms (dbSNP)Bethesda, MDNational Center for Biotechnology Information, National Library of Medicine Available from: http://www.ncbi.nlm.nih.gov/SNP/Accessed January 4, 2016
   Google Scholar
• BarbarinoJMStaatzCEVenkataramananRKleinTEAltmanRBPharmGKB summary: cyclosporine and tacrolimus pathwaysPharmacogenet Genomics2013231056358523922006
   PubMed Web of Science ®Google Scholar
• GenvigirFDSalgadoPCFelipeCRInfluence of the CYP3A4/5 genetic score and ABCB1 polymorphisms on tacrolimus exposure and renal function in Brazilian kidney transplant patientsPharmacogenet Genomics2016261046247227434656
   PubMed Web of Science ®Google Scholar
• 1000 Genomes Project ConsortiumAutonABrooksLDDurbinRMA global reference for human genetic variationNature20155267571687426432245
   PubMed Web of Science ®Google Scholar
• GrossASBest practice in therapeutic drug monitoringBr J Clin Pharmacol199846295999723816
   PubMed Web of Science ®Google Scholar
• CapronAHaufroidVWallemacqPIntra-cellular immunosuppressive drugs monitoring: a step forward towards better therapeutic efficacy after organ transplantation?Pharmacol Res201611161061827468645
   PubMed Web of Science ®Google Scholar
• NocetiOMWoillardJBBoumedieneATacrolimus pharmacodynamics and pharmacogenetics along the calcineurin pathway in human lymphocytesClin Chem201460101336134525142246
   PubMed Web of Science ®Google Scholar
• KrejsaCRoggeMSadeeWProtein therapeutics: new applications for pharmacogeneticsNat Rev Drug Discov20065650752116763661
   PubMed Web of Science ®Google Scholar
• LiaoWLinJXLeonardWJInterleukin-2 at the crossroads of effector responses, tolerance, and immunotherapyImmunity2013381132523352221
   PubMed Web of Science ®Google Scholar
• SeyhunYMytilineosJTurkmenAInfluence of cytokine gene polymorphisms on graft rejection in Turkish patients with renal transplants from living related donorsTransplant Proc20124451241124922663993
   PubMed Web of Science ®Google Scholar
• MorgunAShulzhenkoNRampimGFInterleukin-2 gene polymorphism is associated with renal but not cardiac transplant outcomeTransplant Proc20033541344134512826155
   PubMed Web of Science ®Google Scholar